Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · ScanSource (SCSC)

ScanSource shareholders approve 2024 Omnibus Incentive Compensation Plan at annual meeting

Neutral Impact 2 of 5 shareholder Written later

At its December 10, 2024 annual meeting, ScanSource shareholders approved the 2024 Omnibus Incentive Compensation Plan, which replaces the 2021 plan for future grants. All eight director nominees were elected, and shareholders also approved the advisory say-on-pay vote and ratified Grant Thornton LLP as auditors for fiscal 2025.

Key points

  • 2024 Plan reserves 2,234,543 shares of common stock for awards, plus shares from 2021 Plan awards that later become available
  • No further awards will be granted under the 2021 Plan; outstanding 2021 awards continue under their terms
  • Plan approval received 19,590,961 for votes and 1,215,191 against votes
  • Shareholders represented by proxy held 89.5% of outstanding common stock, or 21,501,384 shares

The filing

CompanyScanSource (SCSC)
Form8-K, current report
Filed with the SECDec 10, 2024, 5:25 PM ET
Accession number0001193125-24-274434

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 10, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.